pfizer-biontech bnt16b2b2 mrna vaccine (BioNTech)
90
Structured Review
BioNTech
pfizer-biontech bnt16b2b2 mrna vaccine
Pfizer Biontech Bnt16b2b2 Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+biontech+bnt16b2b2/pfizer+biontech+bnt16b2b2/pm38997782-41-11-11
Average 90 stars, based on 1 article reviews
Pfizer Biontech Bnt16b2b2 Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+biontech+bnt16b2b2/pfizer+biontech+bnt16b2b2/pm38997782-41-11-11
Average 90 stars, based on 1 article reviews
pfizer-biontech bnt16b2b2 mrna vaccine - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine Article Snippet: Larson et al., 2021 , 83/F , Leukocytoclastic vasculitis , 7 , 2nd , Article Title: Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine Article Snippet: Altun et al., 2021 , 38/M , Leukocytoclastic vasculitis , 4 , 1st , Article Title: Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. Article Snippet: The culprit COVID-19 vaccine types in the study population included Article Title: Multiple lung abscesses and cold agglutinin syndrome following coronavirus disease 2019: a case report. Article Snippet: She had received the fourth dose of COVID-19 vaccination, with the Vaccines:Article Title: Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19. Article Snippet: .. Although approved mRNA vaccines against COVID-19, such as Adjuvant:Article Title: Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19. Article Snippet: .. Although approved mRNA vaccines against COVID-19, such as Ointment:Article Title: Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab Article Snippet: Lladó et al (Spain) , ChAdOx1 (AstraZeneca) , 63; F , First, 9 d , Acitretin 20 mg daily, no follow-up recorded. .. Hunjan et al (United Kingdom) , |
